The Power of 3-7-11 and the Grand Super Cycle: How We Saw the Bullish Turn in April 2025 Back on April 9, 2025, while World Indices were dropping sharply and global sentiment had turned overwhelmingly bearish, we published an article that challenged the fear-driven narrative. We explained why selling was not the right approach and […]
-
Bitcoin Perfectly Reacting Higher From Elliott Wave Blue Box Area
Read MoreIn this technical blog, we will look at the past performance of the Daily Elliott Wave Charts of Bitcoin ticker symbol: $BTCUSD. We presented to members at the elliottwave-forecast. In which, the rally from the 21 November 2022 low is unfolding as an impulse structure. Showing a higher high sequence favored more upside extension to take place. […]
-
Toll Brothers (TOL) Should Pull Back Soon Providing Another Opportunity
Read MoreToll Brothers, Inc., (TOL) designs, builds, markets, sells & arranges finance for the range of detached & attached homes in Luxury residential communities in the United States. It also owns & operates architectural, engineering, mortgage, title, land development, insurance, smart home technology, landscaping, lumber distribution, house component assembly & manufacturing operations. It is headquartered in […]
-
Copper (HG) Double Three Elliott Wave Correction in Progress
Read MoreShort Term Elliott Wave View in Copper (HG) suggests that correction from 5.20.2024 high remains in progress. The internal subdivision of the correction is unfolding as a double three Elliott Wave structure. Down from 5.20.2024 high, wave (W) ended at 4.305 and rally in wave (X) ended at 4.7015. Wave (Y) lower is in progress […]
-
Biotech ETF (XBI) Rallied from the Blue Box Hitting Target
Read MoreThe SPDR S&P Biotech ETF (XBI) is an exchange-traded fund that tracks the biotechnology segment of the S&P Total Market Index. This ETF allows investors to gain exposure to large, mid, and small-cap biotech stocks. If you’re interested in biotechnology, XBI could be worth exploring further. Here are some of its top holdings and their percentage weights: United Therapeutics […]